Evolution Wealth Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Evolution Wealth Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$543.48 - $670.97 $8,695 - $10,735	-16 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$574.03 - $680.96 $16,072 - $19,066	-28 Reduced 63.64%	16 $10,000
Q2 2021 Jul 22, 2021	SELL	$472.8 - $558.54 $15,129 - $17,873	-32 Reduced 42.11%	44 $25,000
Q1 2021 Apr 20, 2021	BUY	$446.73 - $548.2 $31,271 - $38,374	70 Added 1166.67%	76 $36,000
Q2 2020 Jul 27, 2020	BUY	$493.32 - $643.92 $2,959 - $3,863	6 New	6 $4,000
Q1 2020 Apr 22, 2020	SELL	$336.18 - $494.43 $22,187 - $32,632	-66 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$274.13 - $376.51 $17,270 - $23,720	63 Added 2100.0%	66 $25,000
Q3 2019 Nov 12, 2019	SELL	$273.46 - $318.39 $12,305 - $14,327	-45 Reduced 93.75%	3 $1,000
Q2 2019 Jul 12, 2019	BUY	$299.6 - $414.82 $14,380 - $19,911	48 New	48 $15,000

1,532

83.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $80.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.